Loading…
Lobbying Spend
—
Filings
87
Firms Hired
1
Active Period
2003–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Seniors’ Access to Critical Medications Act of 2025
2026 · third_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
Protecting Patient Access to Cancer and Complex Therapies Act
2026 · third_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain; HR4299, Protecting Patient Access to Cancer and Complex Therapies Act.
Client expense: — · Firm income: $60,000
Matched citations: HR4299
Seniors’ Access to Critical Medications Act of 2025
2026 · second_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
Protecting Patient Access to Cancer and Complex Therapies Act
2026 · second_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain; HR4299, Protecting Patient Access to Cancer and Complex Therapies Act.
Client expense: — · Firm income: $60,000
Matched citations: HR4299
Seniors’ Access to Critical Medications Act of 2025
2026 · first_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
Protecting Patient Access to Cancer and Complex Therapies Act
2026 · first_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain; HR4299, Protecting Patient Access to Cancer and Complex Therapies Act.
Client expense: — · Firm income: $60,000
Matched citations: HR4299
Seniors’ Access to Critical Medications Act of 2025
2025 · fourth_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
Seniors’ Access to Critical Medications Act of 2025
2025 · third_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
Seniors’ Access to Critical Medications Act of 2025
2025 · second_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
Seniors’ Access to Critical Medications Act of 2025
2025 · first_quarter · Firm: STANTON PARK GROUP
H.R.2484, Seniors Access to Critical Medications Act of 2025
Client expense: — · Firm income: $60,000
Matched citations: H.R.2484
More Efficient Tools to Realize Information for Consumers Act
2020 · fourth_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act COVID and the impact on cancer care drug pricing regulations
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act COVID and the impact on cancer care drug pricing regulations
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3630
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act COVID and the impact on cancer care drug pricing regulations
Client expense: — · Firm income: $60,000
Matched citations: S. 1895
More Efficient Tools to Realize Information for Consumers Act
2020 · third_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act COVID and the impact on cancer care
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act COVID and the impact on cancer care
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3630
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act COVID and the impact on cancer care
Client expense: — · Firm income: $60,000
Matched citations: S. 1895
More Efficient Tools to Realize Information for Consumers Act
2020 · second_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3630
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: S. 1895
More Efficient Tools to Realize Information for Consumers Act
2020 · first_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3630
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: S. 1895
More Efficient Tools to Realize Information for Consumers Act
2019 · fourth_quarter · Firm: STANTON PARK GROUP
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3630
Medicare, oncology, radiation and imaging reimbursement issues Medicare physician payments prompt pay discount Oncology payment disparities in Medicare and protecting access to community based cancer care Issues related to physician reimbursement for Part B drugs 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices S. 1895, the Lower Health Care Costs Act. H.R. 2296, the FAIR Drug Pricing Act of 2019. H.R. 3630, the No Surprises Act" The Lower Health Care Costs Act
Client expense: — · Firm income: $60,000
Matched citations: S. 1895
Source: Senate LDA